Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Ruzevick

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Neurosurgical Review|November 16, 2013
Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practiceJacob Ruzevick, Lawrence Kleinberg, Daniele Rigamonti
Oral and Maxillofacial Surgery Clinics of North America|March 24, 2024
Pediatric Orbital and Skull Base PathologyDominic Nistal, Amy Lee, Jacob Ruzevick
Immunotherapy|February 19, 2013
Vaccine strategies for glioblastoma: progress and future directionsChristopher Jackson, Jacob Ruzevick, Henry Brem, et al.
Neurosurgery Clinics of North America|July 4, 2012
Clinical trials with immunotherapy for high-grade gliomaJacob Ruzevick, Christopher Jackson, Jillian Phallen, et al.
Oncotarget|December 21, 2020
Advances in meningioma genomics, proteomics, and epigenetics: insights into biomarker identification and targeted therapiesAhmad A Nazem, Jacob Ruzevick, Manuel J Ferreira
Neurosurgery Clinics of North America|July 4, 2012
Potential role for STAT3 inhibitors in glioblastomaChristopher Jackson, Jacob Ruzevick, Anubhav G Amin, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 10, 2021
WHO grade III meningioma: De novo tumors show improved progression free survival as compared to secondary progressive tumorsJacob Ruzevick, Alec Gibson, Philip Tatman, et al.
Current Oncology Reports|July 1, 2017
Tumor Treating Fields in Neuro-Oncological PracticeMaciej M Mrugala, Jacob Ruzevick, Piotr Zlomanczuk, et al.
Clinical & Developmental Immunology|December 23, 2011
Challenges in immunotherapy presented by the glioblastoma multiforme microenvironmentChristopher Jackson, Jacob Ruzevick, Jillian Phallen, et al.
CNS Oncology|October 27, 2015
Pituitary adenomas: historical perspective, surgical management and future directionsDebebe Theodros, Mira Patel, Jacob Ruzevick, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Neurosurgical Review|November 16, 2013
Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practiceJacob Ruzevick, Lawrence Kleinberg, Daniele Rigamonti
Oral and Maxillofacial Surgery Clinics of North America|March 24, 2024
Pediatric Orbital and Skull Base PathologyDominic Nistal, Amy Lee, Jacob Ruzevick
Immunotherapy|February 19, 2013
Vaccine strategies for glioblastoma: progress and future directionsChristopher Jackson, Jacob Ruzevick, Henry Brem, et al.
Neurosurgery Clinics of North America|July 4, 2012
Clinical trials with immunotherapy for high-grade gliomaJacob Ruzevick, Christopher Jackson, Jillian Phallen, et al.
Oncotarget|December 21, 2020
Advances in meningioma genomics, proteomics, and epigenetics: insights into biomarker identification and targeted therapiesAhmad A Nazem, Jacob Ruzevick, Manuel J Ferreira
Neurosurgery Clinics of North America|July 4, 2012
Potential role for STAT3 inhibitors in glioblastomaChristopher Jackson, Jacob Ruzevick, Anubhav G Amin, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 10, 2021
WHO grade III meningioma: De novo tumors show improved progression free survival as compared to secondary progressive tumorsJacob Ruzevick, Alec Gibson, Philip Tatman, et al.
Current Oncology Reports|July 1, 2017
Tumor Treating Fields in Neuro-Oncological PracticeMaciej M Mrugala, Jacob Ruzevick, Piotr Zlomanczuk, et al.
Clinical & Developmental Immunology|December 23, 2011
Challenges in immunotherapy presented by the glioblastoma multiforme microenvironmentChristopher Jackson, Jacob Ruzevick, Jillian Phallen, et al.
CNS Oncology|October 27, 2015
Pituitary adenomas: historical perspective, surgical management and future directionsDebebe Theodros, Mira Patel, Jacob Ruzevick, et al.
Pageof 6